Equities

Kromek Group PLC

KMK:LSE

Kromek Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)7.00
  • Today's Change0.25 / 3.70%
  • Shares traded10.29k
  • 1 Year change-3.40%
  • Beta1.3870
Data delayed at least 20 minutes, as of May 02 2024 09:51 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Kromek Group PLC had net income fall 24.03% from a loss of 4.92m to a larger loss of 6.10m despite a 43.58% increase in revenues from 12.06m to 17.31m. An increase in the selling, general and administrative costs as a percentage of sales from 84.53% to 87.71% was a component in the falling net income despite rising revenues.
Gross margin57.01%
Net profit margin-23.25%
Operating margin-19.38%
Return on assets-6.09%
Return on equity-8.92%
Return on investment-7.33%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Kromek Group PLC fell by 3.98m. Cash Flow from Financing totalled 1.29m or 7.44% of revenues. In addition the company generated 197.00k in cash from operations while cash used for investing totalled 5.27m.
Cash flow per share0.001
Price/Cash flow per share83.69
Book value per share0.0788
Tangible book value per share0.0228
More ▼

Balance sheet in GBPView more

Kromek Group PLC has a Debt to Total Capital ratio of 22.08%, a higher figure than the previous year's 18.13%.
Current ratio2.06
Quick ratio0.9939
Total debt/total equity0.2833
Total debt/total capital0.2208
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.